Clinical Trial Update: Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy and safety in subjects with mild-to-moderate Alzheimer's disease has completed; the document provides an update on trial outco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED